Characterization of a Novel Cyclin-Dependent Kinase 1 Inhibitor, BMI-1026

Cancer Research

Volumn 63, Issue 21, 2003, Pages 7384-7391

  Seong, Yeon Sun ^c   Min, Changhee ^b   Li, Luowei ^a   Yang, Jae Young ^b   Kim, Soo Yeon ^a   Cao, Xiaodong ^b   Kim, Keetae ^b   Yuspa, Stuart H ^a   Chung, Hyun Ho ^b   Lee, Kyung S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b LG Biomedical Institute   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BMI 1026; BMI 1042; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; NOCODAZOLE; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL CULTURE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DEATH; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; ENZYME ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BONE NEOPLASMS; CDC2 PROTEIN KINASE; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE, TUMOR; ENZYME INHIBITORS; KERATINOCYTES; MICE; MITOSIS; OSTEOSARCOMA; PHENOLS; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PYRIMIDINES;

EID: 10744229843     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Morgan, D. O. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol., 13: 261-291, 1997.
2. Sherr, C. J. Cancer cell cycles. Science (Wash. DC), 274: 1672-1677, 1996.
3. Senderowicz, A. M. Cyclin-dependent kinases as targets for cancer therapy. Cancer Chemother. Biol. Response Modif., 20: 169-196, 2002.
4. Meijer, L., and Kim, S. H. Chemical inhibitors of cyclin-dependent kinases. Methods Enzymol., 283: 113-128, 1997.
5. Rialet, V., and Meijer, L. A new screening test for anti-mitotic compounds using the universal M phase-specific protein kinase, p34cdc2/cyclinB cdc13, affinity-immobilized on p13suc1-coated microtitration plates. Anticancer Res., 11: 1581-1590, 1991.
6. Schulze-Gahmen, U., Brandsen, J., Jones, H. D., Morgan, D. O., Meijer, L., Vesely, J., and Kim, S. H. Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomucine and isopentenyladenine. Proteins, 22: 378-391, 1995.
7. DeAzevedo, W. F., Leclerc, S., Meijer, L., Havlicek, L., Strnad, M., and Kim, S. H. Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. Eur. J. Biochem., 243: 518-526, 1997.
8. Kaur, G., Stetler-Stevenson, M., Sebers, S., Worland, P., Sedlacek, H., Myers, C., Czech, J., Naik, R., and Sausville, E. Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275. J. Natl. Cancer Inst. (Bethesda), 84: 1736-1740, 1992.
9. 1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. Cancer Res., 56: 2973-2978, 1996.
10. Losiewicz, M. D., Carlson, B. A., Kaur, G., Sausville, E. A., and Worland, P. J. Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275. Biochem. Biophys. Res. Commun., 201: 589-595, 1994.
11. DeAzevedo, W. F. J., Mueller-Dieckmann, H. J., Schulze-Gahmen, U., Worland, P. J., Sausville, E., and Kim, S. H. Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase. Proc. Natl. Acad. Sci. USA, 93: 2735-2740, 1996.
12. Senderowicz, A. M., and Sausville, E. A. Preclinical and clinical development of cyclin-dependent kinase modulators. J. Natl. Cancer Inst. (Bethesda), 92: 376-387, 2000.
13. 2+ compartments. Cell Growth Differ., 6: 1171-1184, 1995.
14. Strickland, J. E., Greenhalgh, D. A., Koceva-Chyla, A., Hennings, H., Restrepo, C., Balaschak, M., and Yuspa, S. H. Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res., 48: 165-169, 1988.
15. Seong, Y. S., Kamijo, K., Lee, J. S., Fernandez, E., Kuriyama, R., Miki, T., and Lee, K. S. A spindle checkpoint arrest and a cytokinesis failure by the dominant-negative polo-box domain of Plk1 in U-2 OS cells. J. Biol. Chem., 277: 32282-32293, 2002.
16. Lee, K. S., Yuan, Y-L., Kuriyama, R., and Erikson, R. L. Plk is an M-phase-specific protein kinase and interacts with a kinesin-like protein, CHO1/MKLP-1. Mol. Cell. Biol., 15: 7143-7151, 1995.
17. Glover, D. M., Hagan, I. M., and Tavares, A. A. M. Polo-like kinases: a team that plays throughout mitosis. Genes Dev., 12: 3777-3787, 1998.
18. Zhou, H., Kuang, J., Zhong, L., Kuo, W. L., Gray, J. W., Sahin, A., Brinkley, B. R., and Sen, S. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet., 20: 189-193, 1998.
19. Stenoien, D. L., Sen, S., Mancini, M. A., and Brinkley, B. R. Dynamic association of a tumor amplified kinase, Aurora-A, with the centrosome and mitotic spindle. Cell Motil. Cytoskeleton, 55: 134-146, 2003.
20. Kotani, S., Tugendreich, S., Fujii, M., Jorgensen, P., Watanabe, N., Hoog, C., Hieter, P., and Todokoro, K. PKA and MPF-activated polo-like kinase regulate anaphase-promoting complex activity and mitosis progression. Mol. Cell, 1: 371-380, 1998.
21. Patra, D., and Dunphy, W. G. Xe-p9, axenopus Suc1/Cks protein, is essential for the Cdc2-dependent phosphorylation of the anaphase-promoting complex at mitosis. Genes Dev., 12: 2549-2559, 1998.
22. 2/M-phase transition of the cell cycle in Xenopus eggs. J. Cell Sci., 111: 1751-1757, 1998.
23. Kumagai, A., and Dunphy, W. G. Purification and molecular cloning of P1x1, a Cdc25-regulatory kinase from Xenopus egg extracts. Science (Wash. DC), 273: 1377-1380, 1996.
24. Golan, A., Yudkovsky, Y., and Hershko, A. The cyclin-ubiquitin ligase activity of cyclosome/APC is jointly activated by protein kinases Cdk1-cyclin B and Plk. J. Biol. Chem., 277: 15552-15557, 2002.
25. Golsteyn, R. M., Mundt, K. E., Fry, A. M., and Nigg, E. A. Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function. J. Cell Biol., 129: 1617-1628, 1995.
26. Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature (Lond.), 371: 346-347, 1994.
27. Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E., and Poirier, G. G. Specific proteolytic cleavage of poly (ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res., 53: 3976-3985, 1993.
28. Kamb, A. Cyclin-dependent kinase inhibitors and human cancer. Curr. Top. Microbiol. Immunol., 227: 139-148, 1998.
29. Jin, P., Hardy, S., and Morgan, D. O. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J. Cell Biol., 141: 875-885, 1998.